565 related articles for article (PubMed ID: 9212740)
1. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 is a mesangial cell growth factor in vitro and in vivo.
Chadban SJ; Tesch GH; Foti R; Atkins RC; Nikolic-Paterson DJ
Lab Invest; 1997 May; 76(5):619-27. PubMed ID: 9166281
[TBL] [Abstract][Full Text] [Related]
3. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
Martini S; Krämer S; Loof T; Wang-Rosenke Y; Daig U; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1761-70. PubMed ID: 17356129
[TBL] [Abstract][Full Text] [Related]
4. Signal transduction involved in protective effects of 15(R/S)-methyl- lipoxin A(4) on mesangioproliferative nephritis in rats.
Wu SH; Wu XH; Liao PY; Dong L
Prostaglandins Leukot Essent Fatty Acids; 2007 Mar; 76(3):173-80. PubMed ID: 17329090
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats.
Watanabe T; Yamamoto T; Ikegaya N; Fujigaki Y; Suzuki H; Togawa A; Fukasawa H; Nagase M; Hishida A
J Pathol; 2002 Nov; 198(3):397-406. PubMed ID: 12375273
[TBL] [Abstract][Full Text] [Related]
6. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress in the pathogenesis of experimental mesangial proliferative glomerulonephritis.
Budisavljevic MN; Hodge L; Barber K; Fulmer JR; Durazo-Arvizu RA; Self SE; Kuhlmann M; Raymond JR; Greene EL
Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1138-48. PubMed ID: 14600028
[TBL] [Abstract][Full Text] [Related]
9. Modulation of experimental mesangial proliferative nephritis by interferon-gamma.
Johnson RJ; Lombardi D; Eng E; Gordon K; Alpers CE; Pritzl P; Floege J; Young B; Pippin J; Couser WG
Kidney Int; 1995 Jan; 47(1):62-9. PubMed ID: 7731171
[TBL] [Abstract][Full Text] [Related]
10. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G
Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740
[TBL] [Abstract][Full Text] [Related]
11. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle-dependent interleukin 1 gene expression by cultured glomerular mesangial cells.
Lovett DH; Larsen A
J Clin Invest; 1988 Jul; 82(1):115-22. PubMed ID: 3260603
[TBL] [Abstract][Full Text] [Related]
13. Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis.
Tam FW; Smith J; Cashman SJ; Wang Y; Thompson EM; Rees AJ
Am J Pathol; 1994 Jul; 145(1):126-36. PubMed ID: 8030744
[TBL] [Abstract][Full Text] [Related]
14. Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion.
Tomita M; Koike H; Han GD; Shimizu F; Kawachi H
Clin Exp Nephrol; 2004 Mar; 8(1):17-26. PubMed ID: 15067512
[TBL] [Abstract][Full Text] [Related]
15. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis.
Floege J; Eng E; Young BA; Couser WG; Johnson RJ
Kidney Int; 1993 Feb; 43(2):369-80. PubMed ID: 8441232
[TBL] [Abstract][Full Text] [Related]
16. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
Jiang JY; Huang XD; Wang Y; Deng AP; Zhou JH
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 receptor antagonist inhibits subcutaneous B16 melanoma growth in vivo.
McKenzie RC; Oran A; Dinarello CA; Sauder DN
Anticancer Res; 1996; 16(1):437-41. PubMed ID: 8615650
[TBL] [Abstract][Full Text] [Related]
18. Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety.
Burg M; Ostendorf T; Mooney A; Koch KM; Floege J
Lab Invest; 1997 Apr; 76(4):505-16. PubMed ID: 9111513
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis.
Huijun W; Long C; Zhigang Z; Feng J; Muyi G
Exp Mol Pathol; 2005 Feb; 78(1):17-24. PubMed ID: 15596056
[TBL] [Abstract][Full Text] [Related]
20. [Protective effects of 15-methyl-lipoxin A4 on mesangioproliferative nephritis in rats].
Wu SH; Liao PY; Dong L; Jiang XY
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):225-30. PubMed ID: 16787597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
